[
  {
    "NCT ID": "NCT00088881",
    "Brief Title": "Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma",
    "Official Title": "A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients With Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "TERMINATED",
    "Current Phase": "PHASE2",
    "Phase Details": "Phase 2 (Efficacy)",
    "Start Date": "2004-12-01T00:00:00",
    "Completion Date": "2011-03-01T00:00:00",
    "Primary Completion Date": "2011-03-01T00:00:00",
    "Conditions Treated": "Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia",
    "Interventions": "rituximab (BIOLOGICAL); prednisone (DRUG); cyclophosphamide (DRUG); doxorubicin (DRUG); vincristine (DRUG); indium In 111 ibritumomab tiuxetan (RADIATION); radiation therapy (RADIATION); positron emission tomography (PROCEDURE)",
    "Intervention Types": "BIOLOGICAL; DRUG; DRUG; DRUG; DRUG; RADIATION; RADIATION; PROCEDURE",
    "Intervention Names": "rituximab; prednisone; cyclophosphamide; doxorubicin; vincristine; indium In 111 ibritumomab tiuxetan; radiation therapy; positron emission tomography",
    "Lead Sponsor": "National Cancer Institute (NCI)",
    "All Sponsors": "National Cancer Institute (NCI)",
    "Sponsor Types": "NIH",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": true,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": true,
    "Has Radiation Intervention": true,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": true,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": true,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT02021981",
    "Brief Title": "Improving Health Outcomes: Blood Pressure",
    "Official Title": "Improving Health Outcomes: Blood Pressure Program in Practice Sites Located in the Chicago Metropolitan Area and in Maryland",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "UNKNOWN",
    "Current Phase": null,
    "Phase Details": "Not specified",
    "Start Date": "2013-10-01T00:00:00",
    "Completion Date": "2017-07-01T00:00:00",
    "Primary Completion Date": "2017-01-01T00:00:00",
    "Conditions Treated": "Hypertension",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "American Medical Association",
    "All Sponsors": "American Medical Association",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT03719612",
    "Brief Title": "DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY",
    "Official Title": "A Phase III, Open-Label, Multicenter Trial to Evaluate Ejection Fraction, End-Diastolic and End-Systolic Volumes, by Unenhanced and DEFINITY®-Enhanced 2D-Echo and Magnetic Resonance Imaging",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "PHASE3",
    "Phase Details": "Phase 3 (Confirmation)",
    "Start Date": "2018-12-28T00:00:00",
    "Completion Date": "2020-01-09T00:00:00",
    "Primary Completion Date": "2020-01-09T00:00:00",
    "Conditions Treated": "Cardiac Disease",
    "Interventions": "DEFINITY® (DRUG)",
    "Intervention Types": "DRUG",
    "Intervention Names": "DEFINITY®",
    "Lead Sponsor": "Lantheus Medical Imaging",
    "All Sponsors": "Lantheus Medical Imaging",
    "Sponsor Types": "INDUSTRY",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": true,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT00075881",
    "Brief Title": "Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma",
    "Official Title": "Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "PHASE2",
    "Phase Details": "Phase 2 (Efficacy)",
    "Start Date": "2004-01-01T00:00:00",
    "Completion Date": "2012-10-01T00:00:00",
    "Primary Completion Date": "2012-10-01T00:00:00",
    "Conditions Treated": "Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma",
    "Interventions": "bortezomib (DRUG); laboratory biomarker analysis (OTHER)",
    "Intervention Types": "DRUG; OTHER",
    "Intervention Names": "bortezomib; laboratory biomarker analysis",
    "Lead Sponsor": "National Cancer Institute (NCI)",
    "All Sponsors": "National Cancer Institute (NCI)",
    "Sponsor Types": "NIH",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": true,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT05963919",
    "Brief Title": "Determinants of Functional Capacity in Children With Asthma",
    "Official Title": "Determinants of Functional Capacity in Children With Asthma",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": null,
    "Phase Details": "Not specified",
    "Start Date": "2023-01-01T00:00:00",
    "Completion Date": "2023-06-30T00:00:00",
    "Primary Completion Date": "2023-06-30T00:00:00",
    "Conditions Treated": "Asthma in Children",
    "Interventions": "6-minute walk test (OTHER); Pulmonary function test (OTHER); Respiratory muscle strength test (OTHER); Lower extremity muscle strength test (OTHER)",
    "Intervention Types": "OTHER; OTHER; OTHER; OTHER",
    "Intervention Names": "6-minute walk test; Pulmonary function test; Respiratory muscle strength test; Lower extremity muscle strength test",
    "Lead Sponsor": "Atlas University",
    "All Sponsors": "Atlas University",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT07021612",
    "Brief Title": "A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Patients With Pure Aortic Regurgitation",
    "Official Title": "A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Patients With Pure Aortic Regurgitation: An Observational Study",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "RECRUITING",
    "Current Phase": null,
    "Phase Details": "Not specified",
    "Start Date": "2025-04-01T00:00:00",
    "Completion Date": "2028-09-30T00:00:00",
    "Primary Completion Date": "2028-03-31T00:00:00",
    "Conditions Treated": "Aortic Valve Disease",
    "Interventions": "JenaValve (DEVICE); J-Valve (DEVICE)",
    "Intervention Types": "DEVICE; DEVICE",
    "Intervention Names": "JenaValve; J-Valve",
    "Lead Sponsor": "Prince of Wales Hospital, Shatin, Hong Kong",
    "All Sponsors": "Prince of Wales Hospital, Shatin, Hong Kong",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": true,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": true,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT03729765",
    "Brief Title": "Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients",
    "Official Title": "A Randomized, Controlled Trial: Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "RECRUITING",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2018-10-19T00:00:00",
    "Completion Date": "2023-12-31T00:00:00",
    "Primary Completion Date": "2022-01-31T00:00:00",
    "Conditions Treated": "Cardiogenic Shock",
    "Interventions": "hemoperfusion (DEVICE)",
    "Intervention Types": "DEVICE",
    "Intervention Names": "hemoperfusion",
    "Lead Sponsor": "Beijing Anzhen Hospital",
    "All Sponsors": "Beijing Anzhen Hospital",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": true,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": true,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT02489019",
    "Brief Title": "Fentanyl Effect on Blood Pressure in Elderly Patients After Induction of General Anesthesia",
    "Official Title": "Fentanyl Effect on Blood Pressure in Elderly Patients After Induction of General Anesthesia",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "UNKNOWN",
    "Current Phase": "PHASE2, PHASE3",
    "Phase Details": "Phase 2 (Efficacy); Phase 3 (Confirmation)",
    "Start Date": "2018-02-19T00:00:00",
    "Completion Date": "2022-12-01T00:00:00",
    "Primary Completion Date": "2020-07-01T00:00:00",
    "Conditions Treated": "Hypotension",
    "Interventions": "Sodium chloride (DRUG); Fentanyl (DRUG)",
    "Intervention Types": "DRUG; DRUG",
    "Intervention Names": "Sodium chloride; Fentanyl",
    "Lead Sponsor": "Loyola University",
    "All Sponsors": "Loyola University",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": true,
    "Is Phase 3": true,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT01849419",
    "Brief Title": "Effects of MDMA on Social and Emotional Processing",
    "Official Title": "Effects of MDMA on Social and Emotional Processing",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2010-07-01T00:00:00",
    "Completion Date": "2013-03-01T00:00:00",
    "Primary Completion Date": "2013-03-01T00:00:00",
    "Conditions Treated": "Drug Addiction",
    "Interventions": "Within-subjects (MDMA) (DRUG); Within-subjects (oxytocin) (DRUG); Within-subjects (placebo) (DRUG)",
    "Intervention Types": "DRUG; DRUG; DRUG",
    "Intervention Names": "Within-subjects (MDMA); Within-subjects (oxytocin); Within-subjects (placebo)",
    "Lead Sponsor": "University of Chicago",
    "All Sponsors": "University of Chicago",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT00020800",
    "Brief Title": "Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia",
    "Official Title": "Phase II Study of Combination Rituxan (Rituximab, Mabthera) and Fludarabine Therapy in Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "PHASE2",
    "Phase Details": "Phase 2 (Efficacy)",
    "Start Date": "2001-09-01T00:00:00",
    "Completion Date": null,
    "Primary Completion Date": "2003-04-01T00:00:00",
    "Conditions Treated": "Lymphoma",
    "Interventions": "rituximab (BIOLOGICAL); fludarabine phosphate (DRUG)",
    "Intervention Types": "BIOLOGICAL; DRUG",
    "Intervention Names": "rituximab; fludarabine phosphate",
    "Lead Sponsor": "Jonsson Comprehensive Cancer Center",
    "All Sponsors": "Jonsson Comprehensive Cancer Center",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": true,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": true,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT03854500",
    "Brief Title": "The Norwegian Tenecteplase Stroke Trial 2",
    "Official Title": "A Randomised Trial of Tenecteplase vs. Alteplase in Acute Ischemic Stroke",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "TERMINATED",
    "Current Phase": "PHASE3",
    "Phase Details": "Phase 3 (Confirmation)",
    "Start Date": "2019-10-28T00:00:00",
    "Completion Date": "2021-12-31T00:00:00",
    "Primary Completion Date": "2021-09-30T00:00:00",
    "Conditions Treated": "Stroke, Acute; Cerebrovascular Disorders; Ischemic Stroke",
    "Interventions": "Tenecteplase (DRUG); Alteplase (DRUG)",
    "Intervention Types": "DRUG; DRUG",
    "Intervention Names": "Tenecteplase; Alteplase",
    "Lead Sponsor": "Haukeland University Hospital",
    "All Sponsors": "Haukeland University Hospital",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": true,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": true,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT06728592",
    "Brief Title": "Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group",
    "Official Title": "Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "RECRUITING",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2024-12-02T00:00:00",
    "Completion Date": "2027-06-30T00:00:00",
    "Primary Completion Date": "2026-12-31T00:00:00",
    "Conditions Treated": "Ischemic Stroke; Intracerebral Hemorrhage; Stroke; Stroke, Acute; Stroke, Ischemic; Stroke Hemorrhagic; Stroke (CVA) or TIA; Brain Diseases",
    "Interventions": "Portable Magnetic Resonance Imaging (DEVICE)",
    "Intervention Types": "DEVICE",
    "Intervention Names": "Portable Magnetic Resonance Imaging",
    "Lead Sponsor": "Chinese University of Hong Kong",
    "All Sponsors": "Chinese University of Hong Kong",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": true,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": true,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT04471792",
    "Brief Title": "Creatine Use and Muscle Stretching in Peripheral Artery Disease",
    "Official Title": "Creatine Monohydrate Use and Muscle Stretching in Peripheral Artery Disease",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "PHASE2",
    "Phase Details": "Phase 2 (Efficacy)",
    "Start Date": "2020-05-12T00:00:00",
    "Completion Date": "2022-12-15T00:00:00",
    "Primary Completion Date": "2022-12-15T00:00:00",
    "Conditions Treated": "Peripheral Arterial Disease",
    "Interventions": "Creatine monohydrate (DRUG); Cellulose (DIETARY_SUPPLEMENT)",
    "Intervention Types": "DRUG; DIETARY_SUPPLEMENT",
    "Intervention Names": "Creatine monohydrate; Cellulose",
    "Lead Sponsor": "Florida State University",
    "All Sponsors": "Florida State University",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": true,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT02116036",
    "Brief Title": "Rivaroxaban for Antiphospholipid Antibody Syndrome",
    "Official Title": "Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "PHASE4",
    "Phase Details": "Phase 4 (Post-marketing)",
    "Start Date": "2014-09-01T00:00:00",
    "Completion Date": "2017-09-30T00:00:00",
    "Primary Completion Date": "2017-09-30T00:00:00",
    "Conditions Treated": "Antiphospholipid Antibody Syndrome",
    "Interventions": "Rivaroxaban (DRUG)",
    "Intervention Types": "DRUG",
    "Intervention Names": "Rivaroxaban",
    "Lead Sponsor": "St. Joseph's Healthcare Hamilton",
    "All Sponsors": "St. Joseph's Healthcare Hamilton",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": true,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT01594736",
    "Brief Title": "ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography",
    "Official Title": "Intracoronary Stenting and Angiographic Results: ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "PHASE4",
    "Phase Details": "Phase 4 (Post-marketing)",
    "Start Date": "2012-04-01T00:00:00",
    "Completion Date": "2013-06-01T00:00:00",
    "Primary Completion Date": "2013-06-01T00:00:00",
    "Conditions Treated": "Coronary Heart Disease",
    "Interventions": "ORSIRO (DRUG); XIENCE PRIME DES (DEVICE)",
    "Intervention Types": "DRUG; DEVICE",
    "Intervention Names": "ORSIRO; XIENCE PRIME DES",
    "Lead Sponsor": "Deutsches Herzzentrum Muenchen",
    "All Sponsors": "Deutsches Herzzentrum Muenchen",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": true,
    "Has Device Intervention": true,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": true,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  }
]